European Commission call for data on Cannabidiol (CBD)
Ingredients: CANNABIDIOL (CBD)

Date of publication: 01/06/2023

the European Commission launched a call for data on the safety of Cannabidiol (CBD) in pure form, as well as an extract that may contain contaminants of other cannabinoids, including THC at trace levels.

Background

Cannabidiol (CBD) (CAS No. 13956-29-1, EC No. 689-176-3) with the chemical name ‘2-[(6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol’ is included in the European database for information on cosmetic substances and ingredients (CosIng) with the reported functions of ‘skin conditioning’, ‘skin protecting’, ‘antioxidant’, ‘anti-sebum’, etc.

Currently, CBD as such is not regulated under EU Cosmetics Regulation (EC) No 1223/2009. However, entry 306 of Annex II to the EU Cosmetics Regulation prohibits ‘Narcotics, natural and synthetic: All substances listed in Tables I and II of the Single Convention on narcotic drugs signed in New York on 30 March 1961’ for use in cosmetic products.

On 19 November 2020, the Court of Justice of the EU (CJEU) delivered a judgment in Case C-
663/185 concerning the legal status of cannabidiol. In the judgement, the CJEU concluded that
CBD at stake in the main proceedings, should not be considered as a drug under the UN Single
Convention on Narcotic Drugs of 1961.

What’s new?

On 1 June 2023, the European Commission launched a call for data on the safety of Cannabidiol (CBD) (CAS No. 13956-29-1, EC No. 689-176-3) in pure form, as well as an extract that may contain contaminants of other cannabinoids, including trans-Δ⁹-tetrahydrocannabinol (THC or delta-9-THC) (CAS No. 1972-08-3, EC No. 625-153-6), at trace levels.

Considering the very limited available information regarding the safety of CBD in cosmetic
products, the main objective of this call is to gather relevant scientific information to enable the Scientific Committee on Consumer Safety (SCCS) to perform a safety assessment.

Any interested parties, including academic and other research institutes, EU countries’ authorities, manufacturers of cosmetic products, producers of Cannabidiol (CBD) and consumers associations, are invited by the European Commission to submit any relevant scientific information.

Period of consultation: from 1 June 2023 to 30 September 2024 (15 months)

References:

European Commission – Call for data on ingredients used in cosmetic products

Linkedin Instagram Facebook

other REGULATORY UPDATES

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »

Italy and France – Environmental Labelling of Cosmetic Products

PACKAGING WASTE MANAGEMENT

Date of application:01/01/2023

Although the European Cosmetics Regulation is applicable to every cosmetic product made available in the European Union market, some national legislations may also apply. Environmental regulations in Italy and France specify mandatory labelling requirements applicable to packaged products marketed in these countries.

Read More »
Any REGULATORY QUESTION?
E-mail

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »